Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

Abstract How to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression is unclear. Building on a prior study demonstrating the early transformation of FLs with high variant allele frequency (VAF) BCL2 mutations at activation-induced cytidine deaminase...

Full description

Bibliographic Details
Main Authors: Cristina Correia, Matthew J. Maurer, Samantha J. McDonough, Paula A. Schneider, Paige E. Ross, Anne J. Novak, Andrew L. Feldman, James R. Cerhan, Susan L. Slager, Thomas E. Witzig, Bruce W. Eckloff, Hu Li, Grzegorz S. Nowakowski, Scott H. Kaufmann
Format: Article
Language:English
Published: Nature Publishing Group 2023-05-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00847-1

Internet

https://doi.org/10.1038/s41408-023-00847-1

Similar Items